Seroba.

Great news for ARTICA Therapeutics , a Seroba. portfolio company, with the establishment of their Scientific Advisory Board. Excited to see what the future holds with the new members to the team.

Please find below the new report on Life Sciences Investment in the EU unveiled by FTI Consulting and EUCOPE - European Confederation of Pharmaceutical Entrepreneurs. https://lnkd.in/eVtMxCaC Worth a read. Seroba. with Bruno Montanari was happy to participate in this initiative from the investors perspective, and in this pivotal moment for Europe as recently stressed out by the Mario Draghi report. Some key takeaways: the EU benefits from world-class academic research and innovation, but it also faces challenges such as limited availability and access to EU capital, as well as complex market access procedures. The report also aims to draw up a series of recommendations to enhance the EU's attractiveness for LifeSciences investments and to improve access to innovative medicines in Europe. Thank you to FTI Consulting, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs and Broadreach Global. #FuellingInnovation #Europe #Biotech #Seroba

Shorla Oncology, Seroba. portfolio company, has just achieved another great milestone with the FDA Approval of IMKELDI, an oral solution to treat certain forms of leukemia and other cancers. For the US-Irish specialty pharmaceutical company, this marks the fourth FDA approval for oncology treatments. Congratulations to the Shorla team! #Formulation #Innovation #Oncology #VCbacked #SerobaFunding

Another great Office Hours session at PorterShed with additional support from AIB. Thank you to everyone that met with Jennifer McMahon and Sophie Hughes, PhD, and shared their stories. We hope it was a valuable and informative session for all business creators and entrepreneurs.

Great news for Quanta Dialysis Technologies, a Seroba. portfolio company. After their recent FDA clearance, they have now closed on an oversubscribed Series E funding, raising over $60m in capital. With this, they will expand its commercial presence in the US and continue to invest in cutting-edge innovation within the sector. For more information: https://lnkd.in/eBm6Kyn4

Another great opportunity in the portfolio with Loci Orthopaedics! #SerobaVC #Regulatory #Medtech

Seroba portfolio company ShiraTronics, Inc. is hiring a Vice President of Finance in Ireland! Head over to the #ShiraTronics's page to check out the job post and learn more about this exciting opportunity and help to transform the lives of patients with chronic migraine. #Medtech #Finance #NewJob #Hiring

Alan O'Connell and Daniel O'Mahony, partners at Seroba., were delighted to attend the Goodbody celebration of 150 years serving its clients at the beautiful Examination Hall in Trinity College Dublin last night. Bryan Dobson hosted the night with a discussion on how the Irish economy has transformed over recent decades and how we can we continue to build ongoing growth and prosperity with Colin Hunt, CEO, AIB and Frank O'Connor, CEO of National Treasury Management Agency followed by an insightful discussion on the potential transformative impact of AI on the economy.   Thank you to Martin Tormey who walked us through the story of how Robert Goodbody founded the firm in 1874 and how it has grown and thrived over the intervening years and to the Goodbody team for hosting a great evening and congratulations on your 150th! Alan Mahon Cathy Bryce Finlay McFadyen Richard Morton Don Harrington Simon Howley

We are down to our final slots with Office Hours in PorterShed supported by AIB on the 19th November, make sure to grab your slot soon to avoid missing out on this opportunity to meet Jennifer McMahon and Sophie Hughes, PhD to discuss your start-up!

Quanta Dialysis Technologies, a Seroba. portfolio company, received FDA Clearance for home hemodialysis system. This is another milestone for them, expanding further its product offering in the U.S; in hospitals, in-centre clinics, and now in the patient’s home. Seroba are committed to bring accessible care to more patients.